Stifel Financial’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,935
Closed -$85.9K 3463
2025
Q1
$85.9K Buy
14,935
+179
+1% +$1.03K ﹤0.01% 3305
2024
Q4
$73.6K Sell
14,756
-1,352
-8% -$6.75K ﹤0.01% 3284
2024
Q3
$86.8K Buy
16,108
+591
+4% +$3.19K ﹤0.01% 3260
2024
Q2
$51.4K Buy
+15,517
New +$51.4K ﹤0.01% 3278
2024
Q1
Sell
-13,026
Closed -$45.7K 3340
2023
Q4
$45.7K Sell
13,026
-12,297
-49% -$43.2K ﹤0.01% 3230
2023
Q3
$169K Sell
25,323
-13,494
-35% -$90.1K ﹤0.01% 3030
2023
Q2
$326K Buy
38,817
+11,240
+41% +$94.3K ﹤0.01% 2773
2023
Q1
$274K Buy
27,577
+12,649
+85% +$126K ﹤0.01% 2873
2022
Q4
$104K Sell
14,928
-1,000
-6% -$6.96K ﹤0.01% 3128
2022
Q3
$85K Sell
15,928
-3,535
-18% -$18.9K ﹤0.01% 3129
2022
Q2
$78K Sell
19,463
-5,279
-21% -$21.2K ﹤0.01% 3187
2022
Q1
$110K Sell
24,742
-9,835
-28% -$43.7K ﹤0.01% 3247
2021
Q4
$138K Sell
34,577
-34,211
-50% -$137K ﹤0.01% 3222
2021
Q3
$604K Buy
68,788
+12,991
+23% +$114K ﹤0.01% 2464
2021
Q2
$632K Sell
55,797
-10,394
-16% -$118K ﹤0.01% 2439
2021
Q1
$786K Sell
66,191
-25,010
-27% -$297K ﹤0.01% 2159
2020
Q4
$626K Sell
91,201
-4,830
-5% -$33.2K ﹤0.01% 2172
2020
Q3
$712K Sell
96,031
-18,342
-16% -$136K ﹤0.01% 1864
2020
Q2
$477K Buy
114,373
+45,163
+65% +$188K ﹤0.01% 2073
2020
Q1
$168K Sell
69,210
-10,126
-13% -$24.6K ﹤0.01% 2485
2019
Q4
$461K Buy
79,336
+53,236
+204% +$309K ﹤0.01% 2308
2019
Q3
$137K Sell
26,100
-25,449
-49% -$134K ﹤0.01% 2725
2019
Q2
$310K Buy
51,549
+35,030
+212% +$211K ﹤0.01% 2481
2019
Q1
$152K Buy
16,519
+5,765
+54% +$53K ﹤0.01% 2639
2018
Q4
$88K Sell
10,754
-3,200
-23% -$26.2K ﹤0.01% 2575
2018
Q3
$193K Buy
13,954
+3,437
+33% +$47.5K ﹤0.01% 2591
2018
Q2
$85K Buy
10,517
+150
+1% +$1.21K ﹤0.01% 2646
2018
Q1
$79K Buy
+10,367
New +$79K ﹤0.01% 2586